[go: up one dir, main page]

ITMI981670A0 - PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE INHIBITORS 4 - Google Patents

PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE INHIBITORS 4

Info

Publication number
ITMI981670A0
ITMI981670A0 IT98MI001670A ITMI981670A ITMI981670A0 IT MI981670 A0 ITMI981670 A0 IT MI981670A0 IT 98MI001670 A IT98MI001670 A IT 98MI001670A IT MI981670 A ITMI981670 A IT MI981670A IT MI981670 A0 ITMI981670 A0 IT MI981670A0
Authority
IT
Italy
Prior art keywords
phosphodiesterase inhibitors
phthalazine derivatives
derivatives phosphodiesterase
phthalazine
inhibitors
Prior art date
Application number
IT98MI001670A
Other languages
Italian (it)
Inventor
Gabriele Norcini
Franco Pellacini
Gabriele Morazzoni
Mauro Napoletano
Giancarlo Grancini
Gian Marco Leali
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT98MI001670A priority Critical patent/ITMI981670A1/en
Publication of ITMI981670A0 publication Critical patent/ITMI981670A0/en
Priority to PE1999000670A priority patent/PE20000755A1/en
Priority to PCT/EP1999/004904 priority patent/WO2000005218A1/en
Priority to PL99345187A priority patent/PL345187A1/en
Priority to NZ507926A priority patent/NZ507926A/en
Priority to AU52810/99A priority patent/AU765457B2/en
Priority to HR20010057A priority patent/HRP20010057A2/en
Priority to EP03102377A priority patent/EP1371648A1/en
Priority to UA2001010439A priority patent/UA68383C2/en
Priority to MXPA01000670A priority patent/MXPA01000670A/en
Priority to CN99807294A priority patent/CN1127486C/en
Priority to EA200100062A priority patent/EA200100062A1/en
Priority to DE69921139T priority patent/DE69921139T2/en
Priority to IDW20010132A priority patent/ID28874A/en
Priority to AT99938229T priority patent/ATE279397T1/en
Priority to US09/743,813 priority patent/US6329370B1/en
Priority to HK02100584.0A priority patent/HK1039124B/en
Priority to BR9911175-6A priority patent/BR9911175A/en
Priority to IL13949099A priority patent/IL139490A0/en
Priority to YU77500A priority patent/YU77500A/en
Priority to SK100-2001A priority patent/SK1002001A3/en
Priority to JP2000561174A priority patent/JP2002521370A/en
Priority to CA002338044A priority patent/CA2338044A1/en
Priority to EEP200100039A priority patent/EE200100039A/en
Priority to APAP/P/2000/001993A priority patent/AP2000001993A0/en
Priority to HU0102646A priority patent/HUP0102646A3/en
Priority to EP99938229A priority patent/EP1097142B1/en
Priority to OA1200100019A priority patent/OA11582A/en
Priority to KR1020017000971A priority patent/KR20010087161A/en
Priority to ARP990103501A priority patent/AR019409A1/en
Priority to CO99045518A priority patent/CO5090842A1/en
Priority to TW088112218A priority patent/TW509682B/en
Priority to PA19998478301A priority patent/PA8478301A1/en
Publication of ITMI981670A1 publication Critical patent/ITMI981670A1/en
Priority to IS5772A priority patent/IS5772A/en
Priority to BG105063A priority patent/BG105063A/en
Priority to NO20010331A priority patent/NO318988B1/en
Priority to US09/976,436 priority patent/US6492360B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IT98MI001670A 1998-07-21 1998-07-21 PHTHALAZINIC DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4 ITMI981670A1 (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
IT98MI001670A ITMI981670A1 (en) 1998-07-21 1998-07-21 PHTHALAZINIC DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4
PE1999000670A PE20000755A1 (en) 1998-07-21 1999-07-08 PHOSPHODIESTERASE 4 INHIBITING PHTHALAZINE DERIVATIVES
SK100-2001A SK1002001A3 (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
YU77500A YU77500A (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
PL99345187A PL345187A1 (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
NZ507926A NZ507926A (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
AU52810/99A AU765457B2 (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
HR20010057A HRP20010057A2 (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
EP03102377A EP1371648A1 (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
UA2001010439A UA68383C2 (en) 1998-07-21 1999-07-13 Phthalazine derivatives and pharmaceutical compositions
MXPA01000670A MXPA01000670A (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors.
CN99807294A CN1127486C (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
EA200100062A EA200100062A1 (en) 1998-07-21 1999-07-13 PHTHALASINE DERIVATIVES OF THE INHIBITORS OF DERIVATIVES PHOSPHODYSTERASE 4
DE69921139T DE69921139T2 (en) 1998-07-21 1999-07-13 PHTALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS
IDW20010132A ID28874A (en) 1998-07-21 1999-07-13 INHIBITOR PHOSPHODIESTERAGE 4, FTALAZINA DOWN.
AT99938229T ATE279397T1 (en) 1998-07-21 1999-07-13 PHTALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS
US09/743,813 US6329370B1 (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
HK02100584.0A HK1039124B (en) 1998-07-21 1999-07-13 Phthalzaine derivatives phosphodiesterase 4 inhibitors
BR9911175-6A BR9911175A (en) 1998-07-21 1999-07-13 Phthalazine derivatives, pharmaceutical compositions containing them and use as phosphodiesterase 4 inhibitors
PCT/EP1999/004904 WO2000005218A1 (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
IL13949099A IL139490A0 (en) 1998-07-21 1999-07-13 Phthalazine derivatives as phosphodiesterase 4 inhibitors
KR1020017000971A KR20010087161A (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
JP2000561174A JP2002521370A (en) 1998-07-21 1999-07-13 Phthalazine derivative phosphodiesterase 4 inhibitor
CA002338044A CA2338044A1 (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
EEP200100039A EE200100039A (en) 1998-07-21 1999-07-13 Phthalazine derivatives as phosphodiesterase-4 inhibitors
APAP/P/2000/001993A AP2000001993A0 (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors.
HU0102646A HUP0102646A3 (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors and pharmaceutical compositions containing the same
EP99938229A EP1097142B1 (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors
OA1200100019A OA11582A (en) 1998-07-21 1999-07-13 Phthalazine derivatives phosphodiesterase 4 inhibitors.
ARP990103501A AR019409A1 (en) 1998-07-21 1999-07-16 USEFUL FTALACINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTEARASA 4 AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUCH DERIVATIVES
CO99045518A CO5090842A1 (en) 1998-07-21 1999-07-19 INHIBITING PHTALACINIC DERIVATIVES OF PHOSPHODIESTERASE 4
PA19998478301A PA8478301A1 (en) 1998-07-21 1999-07-19 PHTHALACINIC DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4
TW088112218A TW509682B (en) 1998-07-21 1999-07-19 Phthalazine derivatives phosphodiesterase 4 inhibitors
IS5772A IS5772A (en) 1998-07-21 2000-12-15 Phthalazine derivatives of phosphodiesterase4 inhibitors
BG105063A BG105063A (en) 1998-07-21 2000-12-18 Phthalazine derivatives phosphodiestrase 4 inhibitors
NO20010331A NO318988B1 (en) 1998-07-21 2001-01-19 Phthalazine derivatives as phosphodiesterase 4 inhibitors
US09/976,436 US6492360B1 (en) 1998-07-21 2001-10-15 Phthalazine derivatives phosphodiesterase 4 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI001670A ITMI981670A1 (en) 1998-07-21 1998-07-21 PHTHALAZINIC DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4

Publications (2)

Publication Number Publication Date
ITMI981670A0 true ITMI981670A0 (en) 1998-07-21
ITMI981670A1 ITMI981670A1 (en) 2000-01-21

Family

ID=11380474

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98MI001670A ITMI981670A1 (en) 1998-07-21 1998-07-21 PHTHALAZINIC DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4

Country Status (35)

Country Link
US (2) US6329370B1 (en)
EP (2) EP1097142B1 (en)
JP (1) JP2002521370A (en)
KR (1) KR20010087161A (en)
CN (1) CN1127486C (en)
AP (1) AP2000001993A0 (en)
AR (1) AR019409A1 (en)
AT (1) ATE279397T1 (en)
AU (1) AU765457B2 (en)
BG (1) BG105063A (en)
BR (1) BR9911175A (en)
CA (1) CA2338044A1 (en)
CO (1) CO5090842A1 (en)
DE (1) DE69921139T2 (en)
EA (1) EA200100062A1 (en)
EE (1) EE200100039A (en)
HK (1) HK1039124B (en)
HR (1) HRP20010057A2 (en)
HU (1) HUP0102646A3 (en)
ID (1) ID28874A (en)
IL (1) IL139490A0 (en)
IS (1) IS5772A (en)
IT (1) ITMI981670A1 (en)
MX (1) MXPA01000670A (en)
NO (1) NO318988B1 (en)
NZ (1) NZ507926A (en)
OA (1) OA11582A (en)
PA (1) PA8478301A1 (en)
PE (1) PE20000755A1 (en)
PL (1) PL345187A1 (en)
SK (1) SK1002001A3 (en)
TW (1) TW509682B (en)
UA (1) UA68383C2 (en)
WO (1) WO2000005218A1 (en)
YU (1) YU77500A (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (en) * 1997-02-13 2000-09-01 Novartis Ag PHTHALAZINES, PHARMACEUTICAL PREPARATIONS THAT UNDERSTAND THEM AND THE PROCESS FOR THEIR PREPARATION
IT1296984B1 (en) * 1997-12-19 1999-08-03 Zambon Spa PHTHALAZINE DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4
ITMI981671A1 (en) 1998-07-21 2000-01-21 Zambon Spa PHTHALAZINIC DERIVATIVES INHIBITORS OF PHOSPHODISTERASE 4
DE19921567A1 (en) * 1999-05-11 2000-11-16 Basf Ag Use of phthalazine derivatives
DE19963607B4 (en) * 1999-12-23 2005-12-15 Schering Ag Process for the preparation of 4- (heteroaryl-methyl) halo-1 (2H) -phthalazinones
ITMI20000261A1 (en) * 2000-02-16 2001-08-16 Zambon Group PROCESS FOR THE PREPARATION OF PYRIDYLIDEN-PHTHALIDES
US6703390B2 (en) * 2000-04-13 2004-03-09 Transgenomic, Inc. Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors
US6525049B2 (en) * 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
AU2002220241A1 (en) * 2000-12-01 2002-06-11 Iconix Pharmaceuticals, Inc. Parb inhibitors
ITMI20022739A1 (en) * 2002-12-23 2004-06-24 Zambon Spa PHTHALAZINE DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4.
ITMI20022738A1 (en) * 2002-12-23 2004-06-24 Zambon Spa PHTHALAZINE DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4.
AU2004215624B2 (en) * 2003-02-25 2011-06-02 Topotarget Uk Limited Hydroxamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
ITMI20031451A1 (en) * 2003-07-16 2005-01-17 Zambon Spa DIIDRO-FTALAZIN DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4
CA2564996A1 (en) * 2004-05-08 2006-01-12 Taeyoung Yoon 3-aryl-5,6-disubstituted pyridazines
CA2593005A1 (en) * 2005-01-03 2006-07-13 Myriad Genetics Inc. Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
WO2008061108A2 (en) 2006-11-15 2008-05-22 Forest Laboratories Holdings Limited Phthalazine derivatives
WO2010019417A2 (en) * 2008-08-13 2010-02-18 Boehringer Ingelheim International Gmbh Chymase inhibitors
CN102108078B (en) * 2009-12-24 2013-10-30 沈阳药科大学 1,4-substituted phthalazine compound and preparation method and applications thereof
HK1201523A1 (en) * 2011-11-09 2015-09-04 AbbVie Deutschland GmbH & Co. KG Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a
CN117924243B (en) * 2024-01-16 2025-09-12 沈阳药科大学 A quinoline derivative and its pharmaceutical composition and application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2063249A (en) * 1979-10-09 1981-06-03 Mitsubishi Yuka Pharma 4-Phenylphthalazine derivatives
JPH03106873A (en) * 1989-09-20 1991-05-07 Morishita Pharmaceut Co Ltd 1-pyridylphthalazine derivative and inhibitor of blood platelet agglutination containing same derivative
EP0449203B1 (en) * 1990-03-30 1994-12-07 Mitsubishi Chemical Corporation 4-Phenylphthalazine derivatives
EP0634404A1 (en) * 1993-07-13 1995-01-18 Rhone Poulenc Agriculture Ltd. Phtalazin derivatives and their use as pesticides
HU219864B (en) * 1994-08-09 2001-08-28 Eisai Co., Ltd. cGMP-PDE inhibitor condensed pyridazine derivatives and their use
IT1296984B1 (en) * 1997-12-19 1999-08-03 Zambon Spa PHTHALAZINE DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4

Also Published As

Publication number Publication date
ATE279397T1 (en) 2004-10-15
PA8478301A1 (en) 2000-09-29
ITMI981670A1 (en) 2000-01-21
PL345187A1 (en) 2001-12-03
JP2002521370A (en) 2002-07-16
BR9911175A (en) 2001-03-20
OA11582A (en) 2004-07-26
IL139490A0 (en) 2001-11-25
CN1305467A (en) 2001-07-25
KR20010087161A (en) 2001-09-15
DE69921139T2 (en) 2005-10-13
CO5090842A1 (en) 2001-10-30
YU77500A (en) 2002-11-15
AR019409A1 (en) 2002-02-20
EP1097142A1 (en) 2001-05-09
ID28874A (en) 2001-07-12
TW509682B (en) 2002-11-11
MXPA01000670A (en) 2002-05-14
NO20010331D0 (en) 2001-01-19
PE20000755A1 (en) 2000-09-01
DE69921139D1 (en) 2004-11-18
HUP0102646A2 (en) 2001-12-28
US6329370B1 (en) 2001-12-11
EP1371648A1 (en) 2003-12-17
EE200100039A (en) 2002-06-17
EA200100062A1 (en) 2001-08-27
HUP0102646A3 (en) 2003-01-28
NO20010331L (en) 2001-03-20
HK1039124B (en) 2005-04-01
HK1039124A1 (en) 2002-04-12
NZ507926A (en) 2002-10-25
AP2000001993A0 (en) 2000-12-31
US6492360B1 (en) 2002-12-10
IS5772A (en) 2000-12-15
UA68383C2 (en) 2004-08-16
HRP20010057A2 (en) 2002-04-30
CN1127486C (en) 2003-11-12
AU5281099A (en) 2000-02-14
AU765457B2 (en) 2003-09-18
NO318988B1 (en) 2005-05-30
SK1002001A3 (en) 2001-12-03
EP1097142B1 (en) 2004-10-13
WO2000005218A1 (en) 2000-02-03
BG105063A (en) 2001-07-31
CA2338044A1 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
ITMI981671A0 (en) PHTHALAZINE DERIVATIVES PHOSPHODISTERASE INHIBITORS 4
ITMI981670A0 (en) PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE INHIBITORS 4
ATE256123T1 (en) PYRIMIDONE DERIVATIVES
NO20002121D0 (en) Benzothiazol-protein-tyrosine kinase inhibitors
ATE236136T1 (en) BENZOSULFONE DERIVATIVES
NO20010514D0 (en) Aminometylkarboksylsyre derivatives
DE69920697D1 (en) ADENOSINE DERIVATIVES
IS5807A (en) thiobenzimidazole derivative
DE69934788D1 (en) BIOZIDE BENZYLBIPHENYL DERIVATIVE
ATE259810T1 (en) PHENYL-XANTHINE DERIVATIVES
IT1312558B1 (en) ALPHA-KETOAMIDE DERIVATIVES
EE9800219A (en) New 19-nor-pregnene derivatives
IT1296985B1 (en) BENZAZINIC DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4
DK199900820A (en) Earrings
ITMI982216A0 (en) BENZAZINE DERIVATIVES PHOSPHODIESTERASE INHIBITORS 4
DE69911152D1 (en) Symmetrical amplifier
DE69939359D1 (en) AMPLIFIER
ITMI982319A0 (en) TRICYCLIC DERIVATIVES PHOSPHODIESTERASE INHIBITORS 4
DE69837922D1 (en) IL-5 INHIBITOR 6-AZAURACIL DERIVATIVES
NO20011512D0 (en) 2-Phenylpyran-4-one derivatives
ATE252547T1 (en) MATRIXMETALLOPROTEINASE INHIBITORS
DK1134219T3 (en) Cucloalkyl-substituted aminomethylpyrrolidine derivatives
ATE233253T1 (en) CHROMEDER DERIVATIVES
DK1060183T3 (en) 5-deoxycytidine derivatives
IT1289621B1 (en) USE OF TETRAIDROISOCHINOLINA DERIVATIVES